BioSpace News Archive

Drug Development

Quest Launches Alzheimer’s Beta-Amyloid Blood Test for Consumers

Amid a re-energized Alzheimer’s disease space, Quest Diagnostics offers what the company contends is the first direct-to-consumer blood-based biomarker test to assess disease risk.

August 1, 2023
·
2 min read
·
Tristan Manalac
Policy

AstraZeneca Pays $510M to BMS to Settle PD-L1, CTLA-4 Patent Disputes

The settlement agreement between the companies follows three patent-infringement lawsuits filed by Bristol-Myers Squibb over the blockbuster cancer immunotherapies.

August 1, 2023
·
1 min read
·
David Adam
The Military-Biopharma Pipeline: How Service Can Prepare You for Industry Work

Both public and private programs aim to help veterans apply their skills in the biotech and pharmaceutical sector.

August 1, 2023
·
3 min read
·
Shawna Williams
FDA

GSK’s Jemperli Beats Merck’s Keytruda for Frontline Endometrial Cancer Approval

The FDA has approved Jemperli as an add-on to chemotherapy for patients with primary advanced or recurrent endometrial cancer that is mismatch repair deficient or microsatellite instability-high.

August 1, 2023
·
2 min read
·
Tristan Manalac
Deals

Revolution to Buy EQRx in All-Stock Deal, Add $1B in Cash to Balance Sheet

Following difficult recent months for EQRx, the biotech is being bought by Revolution Medicines in an all-stock transaction that secures $1 billion in additional capital for the oncology company.

August 1, 2023
·
2 min read
·
Tristan Manalac
Business

Pfizer Misses on Q2 Revenue as COVID-19 Sales Tank, Narrows 2023 Forecast

In its second-quarter earnings reported Tuesday, Pfizer announced total revenues declined 54% to $12.7 billion, primarily due to a plummet in Paxlovid and Comirnaty sales.

August 1, 2023
·
3 min read
·
Kate Goodwin
Medicenna Strengthens IP Portfolio with U.S. Patent Granted for the Use of Interleukin-2 Superkine Fusion Proteins in Oncology

Medicenna Therapeutics Corp., a clinical stage immunotherapy company, announced the issuance of U.S. Patent No. 11,680,090, titled “Interleukin-2 Fusion Proteins and Uses Thereof.” The patent further strengthens Medicenna’s intellectual property around its BiSKIT™ platform.

August 1, 2023
·
5 min read
Deals

Cybin Announces Size and Pricing of Previously Announced Overnight Marketed Public Offering of Units

Cybin Announces Size and Pricing of Previously Announced Overnight Marketed Public Offering of Units.

August 1, 2023
·
7 min read
Business

Novavax to Host Conference Call to Discuss Second Quarter 2023 Financial Results and Operational Highlights on August 8, 2023

Novavax, Inc. today announced it will report its second quarter 2023 financial results and operational highlights at 8:30 a.m. Eastern Daylight Time (EDT) on Tuesday, August 8, 2023.

August 1, 2023
·
1 min read
FDA

Francis Medical Receives U.S. FDA Breakthrough Device Designation for Vanquish Minimally Invasive Prostate Cancer Therapy

Francis Medical, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its Vanquish minimally invasive water vapor ablation therapy.

August 1, 2023
·
3 min read